Metraipolis › archive › dc_fa69da1f5cfa

Predictors of renal function decline in patients with gastroenteropancreatic neuroendocrine tumors undergoing [177Lu]Lu-DOTA-TATE therapy — Europe PMC PMID:40835788

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40835788
DOI
10.1186/s13550-[numero omesso]-8
License (as archived)
solo-consultazione
Archived
2026-11-10T11:39:45.110Z
SHA-256 of the archived text
c0886a35c8ff26130bdb153705f845e8688a47e6c1f0abe04ecd0335d632d433
Stable URL of this page
https://metraipolis.com/documento/dc_fa69da1f5cfa

How to cite

Predictors of renal function decline in patients with gastroenteropancreatic neuroendocrine tumors undergoing [177Lu]Lu-DOTA-TATE therapy — Europe PMC PMID:40835788 — Europe PMC (en), https://europepmc.org/article/MED/40835788 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fa69da1f5cfa (Metraipolis archive dc_fa69da1f5cfa, sha256 c0886a35c8ff26130bdb153705f845e8688a47e6c1f0abe04ecd0335d632d433)
BibTeX
@misc{dcfa69da1f5cfa,
  title = {Predictors of renal function decline in patients with gastroenteropancreatic neuroendocrine tumors undergoing [177Lu]Lu-DOTA-TATE therapy — Europe PMC PMID:40835788},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40835788},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fa69da1f5cfa; sha256 c0886a35c8ff26130bdb153705f845e8688a47e6c1f0abe04ecd0335d632d433},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40835788. Agents can read the archived copy with the MCP tool read_document.